Optimizing rectal cancer treatment: A path towards personalization Editorial

  

Authors:	Romesser, P. B.; Cercek, A.
Title:	Optimizing rectal cancer treatment: A path towards personalization
Keywords:	treatment outcome; survival rate; clinical feature; cancer recurrence; bevacizumab; fluorouracil; drug efficacy; quality of life; editorial; drug effect; pathology; risk factor; irinotecan; drug response; clinical effectiveness; drug therapy; oxaliplatin; rectal neoplasms; rectum cancer; rectum tumor; therapy; personalized medicine; procedures; nivolumab; humans; human; precision medicine; pembrolizumab; atezolizumab; avelumab; camrelizumab; sintilimab; dostarlimab
Journal Title:	Annals of Oncology
Volume:	35
Issue:	10
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2024-10-01
Start Page:	831
End Page:	835
Language:	English
DOI:	10.1016/j.annonc.2024.08.2349
PUBMED:	39271253
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85203548334&doi=10.1016%2fj.annonc.2024.08.2349&partnerID=40&md5=f926815bbf46a525abcc7aa8e0833219
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/219065